Regarding the molecular pathogenesis of cervical carcinoma associated with high-risk HPV (HR-HPV), all of the following statements are correct EXCEPT:

Explanation

## Molecular Pathogenesis of HPV-Associated Cervical Carcinoma ### Correct Statements (Options 0, 1, 3) **Key Point:** HPV E6 and E7 oncoproteins are the primary drivers of malignant transformation through inactivation of key tumor suppressors. | Oncoprotein | Target | Mechanism | Consequence | | --- | --- | --- | --- | | E6 | p53 | Ubiquitin-mediated proteasomal degradation | Loss of apoptosis, cell cycle arrest, DNA repair | | E7 | Rb protein | Direct binding and inactivation | Uncontrolled G1/S transition, loss of cell cycle control | **High-Yield:** Persistent infection with HR-HPV types 16 and 18 accounts for ~70% of all cervical cancers; types 31, 33, 45, 52, 58 account for most of the remaining ~30%. Overall, HR-HPV is found in >99% of cervical squamous cell carcinomas [cite:Robbins 10e Ch 22]. ### The Incorrect Statement (Option 2) **Warning:** Integration of HPV DNA is NOT mandatory for malignant transformation. - **Episomal persistence:** HR-HPV can persist as an episome (non-integrated circular DNA) in the host cell nucleus and still drive malignant transformation through continuous E6/E7 expression. - **Integration frequency:** While integration occurs in ~90% of invasive cervical cancers, it is NOT a prerequisite—many precancerous lesions (CIN) contain episomal HPV and can progress to cancer. - **Clinical implication:** Integration may accelerate progression and increase genomic instability, but the oncogenic driver is E6/E7 expression, not integration per se. **Clinical Pearl:** Episomal HPV infection can regress spontaneously in immunocompetent hosts; persistent episomal infection with high viral load is a risk factor for progression to CIN and cancer. ### HPV-Associated Cervical Carcinoma Pathogenesis Summary ```mermaid flowchart TD A[HR-HPV Infection]:::outcome --> B{Immune clearance?}:::decision B -->|Yes - within 1-2 yrs| C[Viral clearance]:::outcome B -->|No - persistent| D[Episomal or integrated HPV]:::outcome D --> E[Continuous E6/E7 expression]:::action E --> F[p53 inactivation + Rb inactivation]:::action F --> G[Loss of apoptosis + uncontrolled cell cycle]:::action G --> H[CIN I/II/III]:::outcome H --> I{Additional hits?}:::decision I -->|Yes| J[Invasive cervical cancer]:::urgent I -->|No| K[Possible regression]:::outcome ```